MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on January 7, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on January 7, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on January 7, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on January 7, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Polymyositis and dermatomyositis (second of two parts).
Polymyositis and dermatomyositis: clinical problems.
dermatomyositis.
Histamine (first of two parts).
dermatomyositis: the current position.
Nailfold capillaroscopic changes in dermatomyositis and polymyositis.
Plasma exchange in polymyositis and dermatomyositis.
Risk of cancer in dermatomyositis or polymyositis.
Intravenous immunoglobulin for polymyositis and dermatomyositis.
Polymyositis, dermatomyositis and inclusion-body myositis.
Dystrophin abnormalities in polymyositis and dermatomyositis.
Myasthenia gravis (first of two parts).
Renal transplantation (first of two parts).
Lung defense mechanisms (first of two parts).
Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.
Cyclosporin in the management of polymyositis and dermatomyositis.
Prevalence and incidence of polymyositis and dermatomyositis in Japan.
Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone.
Polymyositis and dermatomyositis as a risk of developing cancer.
dermatomyositis and malignancy risk: a metaanalysis study.
Catecholamines and neurologic diseases (first of two parts).
Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).
Spontaneous electrical muscle fiber activity in polymyositis and dermatomyositis.
Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis.
Polymyositis and dermatomyositis (first of two parts).
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on January 7, 2015. For personal use only. No other uses without p...
776KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Polymyositis and dermatomyositis (second of two parts).
Polymyositis and dermatomyositis: clinical problems.
dermatomyositis.
Histamine (first of two parts).
dermatomyositis: the current position.
Nailfold capillaroscopic changes in dermatomyositis and polymyositis.
Plasma exchange in polymyositis and dermatomyositis.
Risk of cancer in dermatomyositis or polymyositis.
Intravenous immunoglobulin for polymyositis and dermatomyositis.
Polymyositis, dermatomyositis and inclusion-body myositis.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms